Recombinant human erythropoietin in anemia of prematurity

Indian Pediatrics

Volumn 36, Issue 1, 1999, Pages 17-27

  Whitehall, John S ^b   Patole, S K ^b   Campbell, P ^a  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

^b NONE

Author keywords

Anemia; Erythropoietin; Prematurity; Recombinant

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE LIFESPAN; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTENSION; INFANT; IRON THERAPY; MALE; NEUTROPENIA; NUTRITIONAL SUPPORT; PHLEBOTOMY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SEPSIS; STEM CELL;

ADMINISTRATION, ORAL; ANEMIA; BIRTH WEIGHT; ENTERAL NUTRITION; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; HYPERTENSION; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; IRON; MALE; NEUTROPENIA; PHLEBOTOMY; RETICULOCYTES; SAFETY; SEPSIS; SURVIVAL RATE;

EID: 0032895039     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shannon KM, Keith JF, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very-low birthweight preterm infants. Pediatrics 1995; 95: 1-8.
2. Shannon KM, Mentzer WC, Abels RI, Freeman P, Newton N, Thompson D, et al. Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study. J Pediatr 1991; 18: 949-955.
3. Pearson H. Life span of the fetal red blood cell. J Pediatr 1967; 70: 166.
4. Shannon KM. Anemia of prematurity: Progress and prospects. Am J Pediatr Hematol Oncol 1990; 12: 16-22.
5. Stockman JA III, Garcia JF, Oski FA. The anemia of prematurity: Factors governing the erythropoietin response. N Engl J Med. 1977; 296: 647-650.
6. Brown Phibbs RH, Garcia JF, Dallman PR. Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity. J Pediatr 1984; 105: 793-798.
7. Stockman JA III, Graeber JE, Clark DA, McClellan K, Garcia JF, Cavey REN. Anemia of prematurity: Determinants of erythropoietin response. J Pediatr 1984; 105: 786-792.
8. Gairdner D, Marks J, Roscoe JD. Blood formation in infancy. IV. The early anemia of prematurity. Arch Dis Child 1955; 30: 203-211.
9. Shannon KM, Naylor GS, Torkildson JC, demons GK, Schaffner V, Goldman SL, et al. Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med 1987; 317: 728-733.
10. Rhondeau SM, Christensen RD, Ross MP, Rothstein G, Simmons MA. Responsiveness to recombinant erythropoietin of marrow erythroid progenitors in infant with anemia of prematurity. J Pediatr 1988; 112: 935-940.
11. Shannon K. Recombinant human erythropoietin in neonatal anemia. Clin Perinatol 1995; 22: 627-640.
12. Strauss RG. Red blood cell transfusion practices in the newborn. Clin Perinatol 1995; 640-655.
13. Eschbach JW, Egrie JC, Downing MR, Brown JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73-78.
14. Ronnholm KAR, Siimes MA, Hemoglobin concentration depends on protein intake in small preterm infants fed human milk. Arch Dis Child 1985; 60: 99-104.
15. Maier RF, Oblanden M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, et al. The effect of epoietin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994; 330: 1173-1178.
16. Meyer MP, Meyer JH, Commerford A, Mary Hann P, Sive AA, Mailer G. Recombinant human erythropoietin in treatment of the anemia of prematurity: Results of a doble-blind, placebo-controlled study. Pediatrics 1994; 93: 918-923.
17. Merchant RH, Sonigara S, Sanghvi KP. Erythropoietin therapy for anemia of prematurity. Indian Pediatr 1996; 33: 323-326.
18. Carnielli V, Montini G, Riol RD, Dall' Amico R, Cantanitti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992; 121: 98-102.
19. Bechensteen AG, Hags P, Halvorsen S, Whitlaw A, Liestol K, Lindemann R, et al. Erythropoietin, protein, and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child 1993; 69: 19-23.
20. Halperin DS, Wacker P, Lacount G, Felix M, Babel JF, Aapro M, et al. Effects of recombinant human erythropoietin in infants with the anemia of prematurity. J Pediatr 1990; 116: 779-786.
21. Beck D, Masserey, E, Meyer M, Calame A. Traitement intraveineux de l'anemie du premature par erythropoietine humanine recombinee [Abstract]. Schweiz Med Wochenschr 1990; 120 (suppl 34): 11A.
22. Ohls RK, Christensen RD. A randomized trial of erythropoietin administration versus erythrocyte transfusion in patients with the anemia of prematurity [Abstract]. Clin Res 1991; 39: 12A.
23. Shannon KM, Mentzer WC, Abels RI, Freeman P, Newton N, Thompson D, et al. Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study. J Pediatr 1991; 118: 949-955.
24. Obladen M, Maier R, Segerer H, Grauel EL, Holland BM, Stewart G, et al. Efficacy and safety of recombinant human erythropoietin to prevent the anemias of prematurity. Contrib Nephrol 1991; 88: 314-326.
25. Fain J, Hilsenrath PE, Widness JA, Strauss RG, Mutnick AH. A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity. Transfusion. 1995; 35: 936-943.
26. Shireman TI, Hilsenrath PE, Strauss RG, Widness JA, Mutnick AH. Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity: A cost-benefit analysis. Arch Pediatr Adolesc Med. 1994; 148: 582-588.
27. Strauss RG. Recombinant erythropoietin for the anemia of prematurity: Still a promise, not a panancea. J Pediatr 1997; 131: 653-655.